AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Testing of Alzheimer vaccines needed in non-murine models.

Vaccine Weekly

| September 01, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Alzheimer vaccines must be thoroughly tested in non-murine animal models before trials begin in humans.

According to a study from Australia and the United States, "Recent clinical and neuropathological data show that the AN 1792 vaccine enhanced the production of A-beta antibodies in the sera of Alzheimer disease (AD) patients, but it appears to have been ineffective at stimulating the removal of A-beta deposits from the brain or at slowing the rate of cognitive decline. The 19 cases of meningoencephalitis were not linked in an obvious way to serum antibody titer, but they may have been linked to infiltration of the brain by antibodies and/or T-cells. Brain imaging indicated that edema associated with the neuroinflammation did not reflect the typical distribution of neuritic plaques in AD."

"These outcomes were not anticipated by experiments on transgenic mice because compared to humans, these mice have less genetic variability, and their plaques have a different chemical composition, making them far more soluble and easier to remove," said Stephen R. Robinson and collaborators at Monash University and James Cook University in Australia and Case Western Reserve University in the U.S. "Furthermore, the consequences of vaccination are different. Vaccination of transgenic mice removes superfluous human A-beta while ...

Related articles from newspapers, magazines, journals, and more
Mindset and NYU collaborate on novel vaccine technology for Alzheimer...
Newspaper article from: Vaccine Weekly August 28, 2002 700+ words
...can arrest or delay Alzheimer disease. Our goal with the...fibrils that lead to Alzheimer disease. Mindset holds several...prevention and treatment of Alzheimer disease. This article was prepared by Vaccine Weekly editors from staff...
New approaches to Alzheimer disease therapeutics being developed.
Newspaper article from: Vaccine Weekly August 11, 2004 700+ words
...pathogenesis. In Alzheimer disease (AD), the amyloid...the treatment of Alzheimer disease." Small and colleagues...subject areas of Alzheimer Disease, Vaccine Development...was prepared by Vaccine Weekly editors from staff...
Modified response sufficient to enhance cognition in Alzheimer disease.
Newspaper article from: Vaccine Weekly September 22, 2004 700+ words
...cognition in an Alzheimer disease mouse model immunized...improve cognition in Alzheimer disease (AD) model mice...subject areas of Alzheimer Disease, Vaccine Development...was prepared by Vaccine Weekly editors from staff...
Current concepts and future prospects for Alzheimer disease vaccines.
Newspaper article from: Vaccine Weekly May 5, 2004 700+ words
...future prospects for Alzheimer disease vaccines. Alz Dis...publisher of the journal Alzheimer Disease and Associated Disorders...subject areas of Alzheimer Disease Vaccine, Vaccine...was prepared by Vaccine Weekly editors from staff...
Autoimmune reactions to Alzheimer disease vaccine must be eliminated.
Newspaper article from: Vaccine Weekly April 30, 2003 700+ words
...under the major subject areas of Alzheimer's Disease Vaccine, Alzheimer Disease Therapy, Vaccine Safety, Vaccine Development, Geriatrics, and Neurology. This article was prepared by Vaccine Weekly editors from staff and other reports.
Immunotherapy for Alzheimer disease reviewed.
Newspaper article from: Vaccine Weekly December 15, 2004 700+ words
...definitive treatment for Alzheimer disease." Gelinas and his coauthors...major subject areas of Alzheimer Disease Therapy, Alzheimer Disease Vaccine, Vaccine Development...article was prepared by Vaccine Weekly editors from staff and...
Quantitative functional brain mapping assesses progress of Alzheimer disease.
Newspaper article from: Vaccine Weekly November 12, 2003 700+ words
...the progress of Alzheimer disease. "Quantitative...associated with Alzheimer disease," scientists in...subject areas of Alzheimer Disease, Diagnosis, Animal...was prepared by Vaccine Weekly editors from staff...
Amyloid accumulation in Alzheimer disease is response to chronic stress.
Newspaper article from: Vaccine Weekly September 1, 2004 700+ words
...Amyloid accumulation in Alzheimer disease is a response to chronic...major subject areas of Alzheimer Disease, Alzheimer Disease Vaccine, Vaccine Development...article was prepared by Vaccine Weekly editors from staff and...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA